Sverdlov, Oleksandr, Van Dam, Joris, Hannesdottir, Kristin and Thornton-Wells, Tricia (2018) Digital Therapeutics—An Integral Component of Digital Innovation in Drug Development. Clinical pharmacology and therapeutics, 104 (1). pp. 72-80.

Abstract

Digital therapeutics represent a new treatment modality in which digital systems such as smartphone apps are used as regulatory-approved, prescribed therapeutic interventions to treat medical conditions. In this paper, we provide a critical overview of the rationale for investing into such novel modalities, including the unmet medical needs addressed by digital therapeutics and the potential for reducing current costs of medical care. We also discuss emerging pathways to regulatory approval and how innovative business models are enabling further growth in the development of digital therapeutics. We conclude by providing some recent examples of digital therapeutics that have gained regulatory approval and highlight opportunities for the near future.

Item Type:	Article
Date Deposited:	26 Jun 2018 00:45
Last Modified:	26 Jun 2018 00:45
URI:	https://oak.novartis.com/id/eprint/35355